Clinical study of Unani Formulation in patients of pain during menstruatio

Phase 2

• Conditions: Health Condition 1: N944- Primary dysmenorrhea

• Registration Number: CTRI/2024/07/070202
• Lead Sponsor: Faiza Furqan

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 July 2024

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Patients of age group 12 35 years

Patients with regular painful menstruation maybe associated with one or more symptoms like Nausea vomiting diarrhea fatigue

Patients with regular and irregular menstrual cycle

Patients strictly with primary dysmenorrhea

Patients willing to take part in the study

Exclusion Criteria

Patients of age less than 12 and more than 35 years

hormonal and metabolic disorders any organic pelvic pathology

sensitivity to NSAID

Any systemic diseases like hypertension diabetes mellitus and sexually transmitted disease Patients with irregular cycle and flow

Patients with secondary dysmenorrhea

Lactating women

If the subject not willing to continue

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
decrease in VAS and VMSS scores for pain intensityTimepoint: 3 consecutive menstrual cycle

Secondary Outcome Measures

Name	Time	Method
improvement in the quality of life determined by SF 36 health survey questionnaire reduction in the duration of pain associated systemic symptoms and PBLAC score for menstrual blood lossTimepoint: 3 consecutive menstrual cycle